ונקו-טבע 1 גר'

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

VANCOMYCIN AS HYDROCHLORIDE

Pieejams no:

TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL

ATĶ kods:

A07AA09

Zāļu forma:

אבקה מיובשת בהקפאה להזרקה

Kompozīcija:

VANCOMYCIN AS HYDROCHLORIDE 1 G/VIAL

Ievadīšanas:

תוך-ורידי

Receptes veids:

מרשם נדרש

Ražojis:

TEVA PHARMACEUTICAL WORKS PRIVATE LIMITED COMPANY, HUNGARY

Ārstniecības grupa:

VANCOMYCIN

Ārstniecības joma:

VANCOMYCIN

Ārstēšanas norādes:

Vancomycin hydrochloride is indicated for the treatment of severe or serious infections due to susceptible strains of methicillin - resistant (beta-Iactam-resistant) staphylococci. It is also indicated for administration to penicillin-allergic patients as well patients who have failed to respond to or who cannot receive other drugs including cephalosporins or penicillins and for infections due to vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin hydrochloride is indicated for first-line therapy when methicillin-resistant staphylococci are suspected but when susceptibility data become available appropriate therapy should be instituted. Vancomycin hydrochloride is effective in the treatment of staphylococcal endocarditis as well as in other infections due to staphylococci including lower respiratory tract infections septicemia skin and skin - stucture infection and bone infections. Antibiotic therapy is as an adjunct to appropriate surgical measures when staphylococcal

Autorizācija datums:

2010-11-30